News & Articles
Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
-- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Stress Urinary Incontinence
This study will evaluate the long-term effectiveness of an investigational procedure for stress urinary incontinence. If you are a female, aged...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Santa Volunteers Seek Swine Flu Shots
A group of volunteer Santas wants the same swine flu vaccination priority as health care workers and...
FRIDAY, Nov. 27 -- New research suggests that an internal body clock that goes on the fritz could be a factor in the development of bipolar disorder in children.
The finding results from the examination of the genetic makeup of 152 children with...
FRIDAY, Nov. 27 -- A program that gets persistent drunk drivers to consider why they should stop their dangerous behavior may lead to significant and long-lasting changes, researchers have found.
The new study included 184 men and women with two or...
-- A seizure is a sudden spurt of abnormal electrical activity in the brain.
While the causes can be varied and complex, the Epilepsy Foundation offers this list of common triggers:
Missing medications, especially those used to control...
Pharma Industry News
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Nov 25, 2009 - In the
week ending Friday, Nov. 20 – after the American Heart
Association and New England Journal of Medicine released
results of the Arbiter 6-HALTS study on Saturday, Nov. 14...
VANCOUVER, Canada, Nov. 23, 2009-Direct-to-consumer advertising
(DTCA) for a commonly prescribed antiplatelet drug does not appear
associated with increased use, but may be associated with increased
drug costs and Medicaid pharmacy expenditures,...
CHICAGO, Nov. 23, 2009 - Older adults who take several types
of psychotropic medications—such as antidepressants or
sedatives—appear more likely to experience falls, according
to an analysis of previous studies reported in the November...
From Associated Press (November 24, 2009)
BASEL, Switzerland--Swiss pharmaceuticals maker Novartis AG has
opened the first U.S. plant to produce flu vaccines using cell
cultures instead of egg-based methods, it said Tuesday.
The new site in Holly...
Audience: Cardiology and endocrinology healthcare
professionals
ROCKVILLE, Nov. 21, 2009-FDA notified healthcare professionals
and patients that it is reviewing preliminary data from a recent
study suggesting that patients using sibutramine have...
New Drug Approvals
PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Nov 20, 2009 -
Bristol-Myers Squibb Company and Otsuka
Pharmaceutical Co., Ltd. announced today that the U.S. Food and
Drug Administration (FDA) has approved the supplemental New Drug
Application (sNDA)...
Data Show Geodon Used as an Adjunct to Lithium or
Valproate Is Effective in the Maintenance Treatment of Bipolar I
Disorder
NEW YORK--(BUSINESS WIRE)--Nov 20, 2009 - Pfizer today announced
that the U.S. Food and Drug Administration (FDA) has...
Revatio is the Only Treatment in Its Class with Both Oral
and Intravenous Formulations
NEW YORK--(BUSINESS WIRE)--Nov 20, 2009 - Pfizer announced today
that the U.S. Food and Drug Administration (FDA) has approved
Revatio (sildenafil) Injection,...
SAN MATEO, Calif., Nov. 16 /PRNewswire-FirstCall/ -- NeurogesX,
Inc. announced today that the U.S. Food and Drug Administration (FDA)
has approved Qutenza (capsaicin) 8% patch, the first and only
product containing prescription strength...
NEWPORT, Ky., Nov. 16 /PRNewswire/ -- Xanodyne Pharmaceuticals,
Inc., an integrated specialty pharmaceutical company with both
development and commercial capabilities focused on women's
healthcare and pain management, announced today that...
New Drug Applications
ROCKVILLE, Md.--(BUSINESS WIRE)--Nov 25, 2009 - Human Genome
Sciences, Inc. (Nasdaq: HGSI) today announced that it has submitted
a Biologics License Application (BLA) to the U.S. Food and Drug
Administration (FDA) for Zalbin (albinterferon...
POINT RICHMOND, Calif., Nov. 23 /PRNewswire-FirstCall/ --
Transcept Pharmaceuticals, Inc. today announced that it is
scheduled to meet with the U.S. Food and Drug Administration (FDA)
on January 20, 2010 to discuss the Complete Response...
OSLO, Nov. 20, 2009-Hexvix new drug application (NDA) will be
discussed in Oncologic Drugs Advisory Committee meeting scheduled
for 17th December 2009.
Photocure submitted the NDA on 30 June 2009 and achieved a
priority review scheduled to be...
SEATTLE, Nov. 20 /PRNewswire-FirstCall/ -- Dendreon Corporation today announced that the U.S. Food and Drug
Administration (FDA) provided written acknowledgement that the
Company's amended Biologics License Application (BLA) for
Provenge...
WILMINGTON, Del., Nov. 19 /PRNewswire-FirstCall/ -- AstraZeneca
today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration
(FDA) for ticagrelor, an investigational oral antiplatelet
treatment for the...
Clinical Trials
--Poster presentations on studies in cutaneous T-cell,
peripheral T-cell and B-cell lymphoma--
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 24, 2009 - Gloucester
Pharmaceuticals today announced multiple presentations from
clinical and preclinical...
BETHESDA, Md.--(BUSINESS WIRE)--Nov 25, 2009 - Sucampo Pharma
Europe, Ltd., and Sucampo Pharma Americas, Inc., subsidiaries of
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), today presented
additional clinical data for lubiprostone (Amitiza®)
at...
Stockholm, Sweden - November 25, 2009 - Biovitrum AB (STO: BVT)
today announced that the first of two clinical phase II studies,
designed to together show proof of concept of Kiobrina(TM) (rhBSSL)
in preterm infants, has been completed. The results...
NOVATO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Raptor
Pharmaceutical Corp. ("Raptor" or the "Company") (NASDAQ:RPTP) today announced the presentation
of clinical trial data on NGX426, the Company's orally
administered, non-opioid, AMPA/kainate...
New data supports safety of Caldolor over 5 days
of treatment
NASHVILLE, Tenn., Nov. 23 /PRNewswire-FirstCall/ -- Cumberland
Pharmaceuticals Inc. (NASDAQ:CPIX) today announced positive new
top-line results from a study evaluating the safety...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
Monthly Update Archive
